v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Operating activities:          
Net income $ 61,634 $ 216,587 $ 144,427 $ 335,940  
Adjustments to reconcile net income to net cash provided by in operating activities:          
Share-based compensation     17,174 15,694  
Depreciation and amortization 2,000 700 3,931 2,224  
Amortization of intangibles 27,193 0 38,596 0  
Amortization of debt discount     6,007 2,674  
Accretion of discounts on marketable securities, net     985 1,518  
Realized loss on marketable securities     1,727 0  
Loss on disposal of equipment     80 0  
Recognition of deferred revenue     (1,573) (997)  
Lease payments deferred     (638) (568)  
Induced conversion expense related to convertible notes 2,712 0 2,712 20,960 $ 21,000
Deferred income taxes     25,329 (142,481)  
Other     (228) (4)  
Changes in operating assets and liabilities:          
Accounts receivable, net and other contract assets     (76,186) (14,369)  
Inventories     (14,536) 5,152  
Prepaid expenses and other assets     (14,359) (6,513)  
Accounts payable and accrued expenses     24,209 (2,306)  
Net cash provided by operating activities     157,657 216,924  
Investing activities:          
Purchases of marketable securities     (225,689) (283,354)  
Proceeds from sales and maturities of marketable securities     725,995 177,833  
Acquisitions of business, net of cash acquired     (999,120) 0  
Purchases of property and equipment     (2,466) (1,299)  
Proceeds from the sale of assets     16,021 0  
Net cash used in investing activities     (485,259) (106,820)  
Financing activities:          
Proceeds from term loan     250,000 0  
Repayment of term loan     250,000 0  
Proceeds from revolving credit facilities     120,000 0  
Repayment of revolving credit facilities     (120,000) 0  
Proceeds from issuance of 2027 and 2028 Convertible Notes     702,000 784,875  
Repayment of 2024 Convertible Notes     (77,453) (369,064)  
Purchase of capped call     (69,120) 0  
Payment of debt issuance cost     (6,465) (424)  
Repurchase of common stock     (200,001) (189,737)  
Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement     7,081 8,226  
Net cash provided by financing activities     356,042 233,876  
Net increase in cash, cash equivalents and restricted cash     28,440 343,980  
Cash, cash equivalents and restricted cash at beginning of period     119,219 148,203 148,203
Cash, cash equivalents and restricted cash at end of period $ 147,659 $ 492,183 147,659 492,183 $ 119,219
Supplemental disclosure of non-cash investing and financing activities:          
Amounts accrued for purchases of property and equipment     319 102  
Right-of-use assets obtained in exchange for lease obligation     970 318  
Debt issuances cost included in accounts payable     639 0  
Common stock issued for induced conversion related to convertible notes     $ 1,019 $ 7,865